FCS Software Q1: consolidated PAT climbs to ₹0.63 Cr on 83% revenue surge led by non-IT arms
PAT +6161% YoY · revenue +83% · margins expanding
₹16.12 Cr
+83% YoY
₹0.63 Cr
+6161% YoY
3.44%
-0.5pp YoY
₹0.004
FCS Software Solutions posted a sharply improved consolidated Q1 FY27 (quarter ended June 30, 2026): revenue from operations of ₹16.12 Cr rose ~83% YoY from ₹8.81 Cr, total income reached ₹18.29 Cr, and net profit swung to ₹0.63 Cr from a near-breakeven ₹0.01 Cr a year ago — net margin expanding to ~3.4% from effectively nil. The headline growth, however, is driven by the group's non-IT businesses rather than the core software operation: consolidated expenses now include ₹4.62 Cr of purchase of stock-in-trade (a trading line absent from the standalone accounts), and the material subsidiary Bloom Healthcare & Hospitality contributed ₹9.94 Cr of revenue (though it ran a small ₹0.05 Cr net loss). Standalone, which isolates the legacy IT services business, tells a softer story — revenue up a modest ~9.5% YoY to ₹8.02 Cr and PAT of ₹0.68 Cr actually down ~26% YoY, with the prior-year standalone figure flattered by a ₹0.78 Cr exceptional gain. This standalone-vs-consolidated divergence is material and readers should treat FCS as a diversifying group, not a pure IT play.
Q1 FY-2027 vs prior quarters
Sequentially the quarter reads weak: consolidated revenue fell ~40% and PAT ~88% from Q4 FY26's ₹26.77 Cr and ₹5.40 Cr, but the March quarter was inflated (it carries year-end balancing figures and a heavier trading/stock-in-trade contribution), so QoQ is not a clean comparison. No analyst or consensus estimates exist for this ₹1-face-value micro-cap, and management provides no formal guidance or concall outlook on record, so the print cannot be benchmarked against street or prior guidance. The results are unaudited and limited-reviewed by SPMG & Co with an unmodified conclusion; the board approved them at its July 25, 2026 meeting, the only corporate development of note this quarter. Net: genuine YoY topline and margin improvement, but the gains sit in newer non-IT subsidiaries while the core IT unit's profitability slipped.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS ₹0.004 (not annualised) on ₹1 face value — ~170.96 crore shares outstanding.
W1
Durability of the ₹4.62 Cr stock-in-trade trading revenue that drove the consolidated topline this quarter.
W2
Bloom Healthcare & Hospitality trajectory — ₹9.94 Cr revenue but a ₹0.05 Cr net loss; watch for a turn to profit.
W3
Core standalone IT profitability, down ~26% YoY to ₹0.68 Cr, against modest ~9.5% revenue growth.
Source in ₹ Lacs, converted to Cr (÷100). No exceptional items this quarter (cons or SA); SA year-ago Jun-25 had a ₹0.78 Cr exceptional gain. Cons PAT YoY is off a near-breakeven base (₹0.01 Cr). PDF-reported year-ago cons figures (rev ₹8.81 Cr, PAT ₹0.01 Cr) differ from our DB record (rev ₹8.31 Cr, PAT ₹0.43 Cr); anchored YoY on the PDF's own comparative column. Cons PBT ₹0.97 Cr is after ₹0.001 Cr associate loss.